Collaboration empowers organizations to achieve carbon commitments and holds companies accountable for turning commitment into action. My Green Lab is proud to announce our renewed partnership with the United Nations High-Level Climate Champions. Supporting the United Nations’ Race to Zero Campaign, which aims to halve global carbon emissions by 2030, this renewed collaboration will empower more organizations than ever to achieve their carbon commitments through My Green Lab’s programs and research.
Building on the success of the current partnership in advancing the biotech and pharma industry’s commitments, the renewed partnership will more broadly address the healthcare value chain. My Green Lab’s VP of Investments and Partnerships, Ryan Arnold, has been appointed the Health Sector Lead at the High-Level Climate Champions. “Biotech and pharma play a huge role within the sector, but there are more opportunities across the healthcare value chain where My Green Lab’s tools can help drive systemic change,” says Arnold. My Green Lab Certification was selected as a Race to Zero Breakthrough Outcome in 2021, establishing a target that 95% of labs in biotech and pharma achieve Certification at the highest level by 2030. Over 2,000 labs and 24,000 scientists from 45 countries have engaged with the program, including 35 of the largest biotech and pharma companies. Currently, 71% of companies in the sector with over $1 billion in revenue that have joined the Race to Zero are working on a My Green Lab Certification. The rapidly growing program is recognized as the gold standard for laboratory sustainability best practices worldwide. In addition to ensuring the adoption of My Green Lab Certification in laboratories, the renewed partnership will build upon My Green Lab’s groundbreaking report on the carbon impact of biotech and pharma that tracks the industry's progress to net zero carbon. “With only seven years until 2030, we must urgently accelerate the decarbonization of all parts of the economy. My Green Lab has been our key partner since 2022 to align the pharma and biotech sector with the goals of the Paris Agreement. This year, we’re thrilled to expand our partnership to the whole health sector and focus on both decarbonization and resilience in the frame of the 2030 Breakthroughs and the Sharm El Sheikh Adaptation Agenda, with expected highlights at COP28,” says Emmanuelle Pinault, Director of Systems Transformation, High-Level Climate Champions. Comments are closed.
|